C-Nate DHA

Product NDC

23359-105

11-digit product format

233590105

Labeler code

23359

Product ID

23359-105_d46a8303-847f-8c48-e053-2995a90a08e0

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

omega-3 fatty acids, icosapent, doconexent, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, folic acid, cholecalciferol, ascorbic acid, .alpha.-tocopherol, d-, cupric sulfate, zinc oxide, ferrous fumarate and magnesium oxide

Dosage form

CAPSULE, GELATIN COATED

Route

ORAL

Labeler

Centurion Labs, LLC

Marketing category

UNAPPROVED DRUG OTHER

Marketing start

2013-01-01

Marketing end

0000-00-00

Substance

OMEGA-3 FATTY ACIDS; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; FOLIC ACID; CHOLECALCIFEROL; ASCORBIC ACID; .ALPHA.-TOCOPHEROL, D-; CUPRIC SULFATE; ZINC OXIDE; FERROUS FUMARATE; MAGNESIUM

Active strength

200 mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1

Pharmacologic classes

Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Vitamin D [CS],Vitamin D [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE]

NDC exclude flag

No

Listing certified through

2022-12-31

Current FDA listing

Historical FDA.report record